Biosenta Statistics
Total Valuation
Biosenta has a market cap or net worth of CAD 4.57 million. The enterprise value is 10.70 million.
Market Cap | 4.57M |
Enterprise Value | 10.70M |
Important Dates
The last earnings date was Thursday, May 29, 2025.
Earnings Date | May 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Biosenta has 33.83 million shares outstanding. The number of shares has increased by 13.33% in one year.
Current Share Class | 33.83M |
Shares Outstanding | 33.83M |
Shares Change (YoY) | +13.33% |
Shares Change (QoQ) | +1.51% |
Owned by Insiders (%) | 26.07% |
Owned by Institutions (%) | 6.47% |
Float | 18.75M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2,562.98 |
PB Ratio | -0.51 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.23 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -19.01 |
Financial Position
The company has a current ratio of 0.03
Current Ratio | 0.03 |
Quick Ratio | 0.02 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -10.91 |
Interest Coverage | -1.02 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -525.29% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 39.12% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.01 |
Inventory Turnover | 0.02 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.75% in the last 52 weeks. The beta is 0.03, so Biosenta's price volatility has been lower than the market average.
Beta (5Y) | 0.03 |
52-Week Price Change | -63.75% |
50-Day Moving Average | 0.13 |
200-Day Moving Average | 0.14 |
Relative Strength Index (RSI) | 76.31 |
Average Volume (20 Days) | 1,475 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biosenta had revenue of CAD 1,782 and -2.53 million in losses. Loss per share was -0.08.
Revenue | 1,782 |
Gross Profit | 1,088 |
Operating Income | -1.26M |
Pretax Income | -2.53M |
Net Income | -2.53M |
EBITDA | -1.26M |
EBIT | -1.26M |
Loss Per Share | -0.08 |
Balance Sheet
The company has 4,215 in cash and 6.14 million in debt, giving a net cash position of -6.14 million or -0.18 per share.
Cash & Cash Equivalents | 4,215 |
Total Debt | 6.14M |
Net Cash | -6.14M |
Net Cash Per Share | -0.18 |
Equity (Book Value) | -8.95M |
Book Value Per Share | -0.27 |
Working Capital | -3.27M |
Cash Flow
In the last 12 months, operating cash flow was -537,161 and capital expenditures -25,861, giving a free cash flow of -563,022.
Operating Cash Flow | -537,161 |
Capital Expenditures | -25,861 |
Free Cash Flow | -563,022 |
FCF Per Share | -0.02 |
Margins
Gross Margin | 61.05% |
Operating Margin | -70,896.46% |
Pretax Margin | -141,906.62% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Biosenta does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -13.33% |
Shareholder Yield | n/a |
Earnings Yield | -55.37% |
FCF Yield | -12.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on June 28, 2016. It was a reverse split with a ratio of 0.0666666666.
Last Split Date | Jun 28, 2016 |
Split Type | Reverse |
Split Ratio | 0.0666666666 |
Scores
Biosenta has an Altman Z-Score of -338.23. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -338.23 |
Piotroski F-Score | n/a |